2Tapson VF. Treatment of pulmonary embolism:Anticoagulation, thrombolytic therapy, and complications of therapy[J]. Crit Care Clin,2011,27(4):825 -839.
4Samama MM. A silent killer: exploring the burden of VTE in medical patients[ M]. In: VTE Experts Meeting. Belgium,2004,51 -76.
5Mark H,Merssner MD,D Eugene Strandness, Jr, MD. Pathophysiology and natural history of acute deep venous thrombosis. In: Rotherford RB eds[M]. Vascular Surgery. 5th ed. Philadelphia: W. B. Saunders, 2005,1698.
6Delis KT, Bountouroglon D, Mansfield AD. Venous clandicaition in iliofemoral thrombosis: long-term effects on venous hemodynamics, clinical status, and quality of life[J]. Ann Surg, 2004,239:118 -126.
7Clive Kearon, Susan R Kahn, Gianearlo Agnelli, et al. Comerota, Antithrombotle Therapy for Venous Thromboembolism Disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines ( 8th Edition) [ J]. Chest,2008,133:454 - 545.
10Silbersack L, Taute BM, Hein W, et al. Prevention of deep-vein thrombosis after total hip and knee replacement: low -molecular weight heparin in combination with intermittent pneumatic compression[J]. J Bone Joint Surg,2004,86:809 -812.
2Tapson VF. Treatment of pulmonary embolism: anticoagulation, thrombolytic therapy, and complications of therapy[J]. Crit Care Clin,2011,27(4):825-839.
